Logo image of EHAB

ENHABIT INC (EHAB) Stock Fundamental Analysis

USA - New York Stock Exchange - NYSE:EHAB - US29332G1022 - Common Stock

9.51 USD
+0.07 (+0.74%)
Last: 1/7/2026, 8:04:00 PM
9.68 USD
+0.17 (+1.79%)
After Hours: 1/7/2026, 8:04:00 PM
Fundamental Rating

4

Taking everything into account, EHAB scores 4 out of 10 in our fundamental rating. EHAB was compared to 101 industry peers in the Health Care Providers & Services industry. While EHAB is still in line with the averages on profitability rating, there are concerns on its financial health. EHAB is valued correctly, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

EHAB had positive earnings in the past year.
In the past year EHAB had a positive cash flow from operations.
In multiple years EHAB reported negative net income over the last 5 years.
Each year in the past 5 years EHAB had a positive operating cash flow.
EHAB Yearly Net Income VS EBIT VS OCF VS FCFEHAB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M -150M

1.2 Ratios

EHAB has a Return On Assets (-0.97%) which is comparable to the rest of the industry.
EHAB's Return On Equity of -2.10% is in line compared to the rest of the industry. EHAB outperforms 51.49% of its industry peers.
EHAB's Return On Invested Capital of 4.51% is in line compared to the rest of the industry. EHAB outperforms 51.49% of its industry peers.
The Average Return On Invested Capital over the past 3 years for EHAB is significantly below the industry average of 9.21%.
The last Return On Invested Capital (4.51%) for EHAB is above the 3 year average (3.74%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA -0.97%
ROE -2.1%
ROIC 4.51%
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
EHAB Yearly ROA, ROE, ROICEHAB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 0 -10 -20

1.3 Margins

EHAB's Operating Margin of 5.96% is fine compared to the rest of the industry. EHAB outperforms 65.35% of its industry peers.
In the last couple of years the Operating Margin of EHAB has declined.
Looking at the Gross Margin, with a value of 48.98%, EHAB is in the better half of the industry, outperforming 74.26% of the companies in the same industry.
In the last couple of years the Gross Margin of EHAB has remained more or less at the same level.
Industry RankSector Rank
OM 5.96%
PM (TTM) N/A
GM 48.98%
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
EHAB Yearly Profit, Operating, Gross MarginsEHAB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 0 20 40

3

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), EHAB is destroying value.
Compared to 1 year ago, EHAB has more shares outstanding
The debt/assets ratio for EHAB is higher compared to a year ago.
EHAB Yearly Shares OutstandingEHAB Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M
EHAB Yearly Total Debt VS Total AssetsEHAB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

EHAB has an Altman-Z score of 1.68. This is a bad value and indicates that EHAB is not financially healthy and even has some risk of bankruptcy.
EHAB has a Altman-Z score of 1.68. This is in the lower half of the industry: EHAB underperforms 60.40% of its industry peers.
EHAB has a debt to FCF ratio of 8.01. This is a slightly negative value and a sign of low solvency as EHAB would need 8.01 years to pay back of all of its debts.
EHAB has a Debt to FCF ratio (8.01) which is comparable to the rest of the industry.
EHAB has a Debt/Equity ratio of 0.78. This is a neutral value indicating EHAB is somewhat dependend on debt financing.
EHAB has a Debt to Equity ratio (0.78) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 8.01
Altman-Z 1.68
ROIC/WACC0.47
WACC9.57%
EHAB Yearly LT Debt VS Equity VS FCFEHAB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 500M 1B

2.3 Liquidity

A Current Ratio of 1.58 indicates that EHAB should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.58, EHAB is in the better half of the industry, outperforming 61.39% of the companies in the same industry.
A Quick Ratio of 1.58 indicates that EHAB should not have too much problems paying its short term obligations.
The Quick ratio of EHAB (1.58) is better than 64.36% of its industry peers.
Industry RankSector Rank
Current Ratio 1.58
Quick Ratio 1.58
EHAB Yearly Current Assets VS Current LiabilitesEHAB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 50M 100M 150M 200M

3

3. Growth

3.1 Past

EHAB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 91.30%, which is quite impressive.
The Revenue has been growing slightly by 1.02% in the past year.
Measured over the past years, EHAB shows a decrease in Revenue. The Revenue has been decreasing by -1.07% on average per year.
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%

3.2 Future

EHAB is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.82% yearly.
EHAB is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.22% yearly.
EPS Next Y165.2%
EPS Next 2Y64.92%
EPS Next 3Y40.96%
EPS Next 5Y7.82%
Revenue Next Year2.46%
Revenue Next 2Y3.22%
Revenue Next 3Y3.54%
Revenue Next 5Y5.22%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
EHAB Yearly Revenue VS EstimatesEHAB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 200M 400M 600M 800M 1B
EHAB Yearly EPS VS EstimatesEHAB Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 2029 0.5 1

6

4. Valuation

4.1 Price/Earnings Ratio

EHAB is valuated rather expensively with a Price/Earnings ratio of 21.61.
Based on the Price/Earnings ratio, EHAB is valued a bit cheaper than 68.32% of the companies in the same industry.
When comparing the Price/Earnings ratio of EHAB to the average of the S&P500 Index (26.92), we can say EHAB is valued inline with the index average.
With a Price/Forward Earnings ratio of 16.65, EHAB is valued correctly.
74.26% of the companies in the same industry are more expensive than EHAB, based on the Price/Forward Earnings ratio.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.57, EHAB is valued a bit cheaper.
Industry RankSector Rank
PE 21.61
Fwd PE 16.65
EHAB Price Earnings VS Forward Price EarningsEHAB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, EHAB is valued a bit cheaper than the industry average as 73.27% of the companies are valued more expensively.
Based on the Price/Free Cash Flow ratio, EHAB is valued cheaper than 89.11% of the companies in the same industry.
Industry RankSector Rank
P/FCF 8.31
EV/EBITDA 10.06
EHAB Per share dataEHAB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
EHAB's earnings are expected to grow with 40.96% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.13
PEG (5Y)N/A
EPS Next 2Y64.92%
EPS Next 3Y40.96%

0

5. Dividend

5.1 Amount

EHAB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

ENHABIT INC

NYSE:EHAB (1/7/2026, 8:04:00 PM)

After market: 9.68 +0.17 (+1.79%)

9.51

+0.07 (+0.74%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)11-05 2025-11-05/amc
Earnings (Next)03-03 2026-03-03/amc
Inst Owners104.3%
Inst Owner ChangeN/A
Ins Owners2.33%
Ins Owner Change8.93%
Market Cap481.30M
Revenue(TTM)1.05B
Net Income(TTM)-11.90M
Analysts76.36
Price Target9.95 (4.63%)
Short Float %3.41%
Short Ratio3.47
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)31.12%
Min EPS beat(2)23.34%
Max EPS beat(2)38.89%
EPS beat(4)3
Avg EPS beat(4)21.77%
Min EPS beat(4)-28.32%
Max EPS beat(4)53.19%
EPS beat(8)6
Avg EPS beat(8)34.93%
EPS beat(12)7
Avg EPS beat(12)12.51%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-2.11%
Min Revenue beat(2)-3.27%
Max Revenue beat(2)-0.95%
Revenue beat(4)0
Avg Revenue beat(4)-2.69%
Min Revenue beat(4)-4.23%
Max Revenue beat(4)-0.95%
Revenue beat(8)0
Avg Revenue beat(8)-3.24%
Revenue beat(12)0
Avg Revenue beat(12)-3.7%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)4%
PT rev (3m)4%
EPS NQ rev (1m)0%
EPS NQ rev (3m)3.26%
EPS NY rev (1m)0%
EPS NY rev (3m)10.53%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.37%
Valuation
Industry RankSector Rank
PE 21.61
Fwd PE 16.65
P/S 0.46
P/FCF 8.31
P/OCF 7.73
P/B 0.85
P/tB N/A
EV/EBITDA 10.06
EPS(TTM)0.44
EY4.63%
EPS(NY)0.57
Fwd EY6.01%
FCF(TTM)1.14
FCFY12.03%
OCF(TTM)1.23
OCFY12.94%
SpS20.7
BVpS11.2
TBVpS-7.48
PEG (NY)0.13
PEG (5Y)N/A
Graham Number10.53
Profitability
Industry RankSector Rank
ROA -0.97%
ROE -2.1%
ROCE 5.71%
ROIC 4.51%
ROICexc 4.76%
ROICexgc 54.35%
OM 5.96%
PM (TTM) N/A
GM 48.98%
FCFM 5.53%
ROA(3y)-7%
ROA(5y)-1.92%
ROE(3y)-15.77%
ROE(5y)-6.79%
ROIC(3y)3.74%
ROIC(5y)4.76%
ROICexc(3y)3.81%
ROICexc(5y)4.84%
ROICexgc(3y)39.56%
ROICexgc(5y)58.49%
ROCE(3y)4.73%
ROCE(5y)6.02%
ROICexgc growth 3Y-27.94%
ROICexgc growth 5YN/A
ROICexc growth 3Y-21.68%
ROICexc growth 5YN/A
OM growth 3Y-29.61%
OM growth 5Y-4.28%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.12%
GM growth 5Y-1.19%
F-Score7
Asset Turnover0.85
Health
Industry RankSector Rank
Debt/Equity 0.78
Debt/FCF 8.01
Debt/EBITDA 5.02
Cap/Depr 17.25%
Cap/Sales 0.42%
Interest Coverage 1.77
Cash Conversion 70.88%
Profit Quality N/A
Current Ratio 1.58
Quick Ratio 1.58
Altman-Z 1.68
F-Score7
WACC9.57%
ROIC/WACC0.47
Cap/Depr(3y)51.64%
Cap/Depr(5y)35.82%
Cap/Sales(3y)1.58%
Cap/Sales(5y)1.12%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)91.3%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%466.67%
EPS Next Y165.2%
EPS Next 2Y64.92%
EPS Next 3Y40.96%
EPS Next 5Y7.82%
Revenue 1Y (TTM)1.02%
Revenue growth 3Y-2.21%
Revenue growth 5Y-1.07%
Sales Q2Q%3.94%
Revenue Next Year2.46%
Revenue Next 2Y3.22%
Revenue Next 3Y3.54%
Revenue Next 5Y5.22%
EBIT growth 1Y60.82%
EBIT growth 3Y-31.17%
EBIT growth 5Y-5.31%
EBIT Next Year78.82%
EBIT Next 3Y23.25%
EBIT Next 5YN/A
FCF growth 1Y632.91%
FCF growth 3Y-26.15%
FCF growth 5Y0%
OCF growth 1Y25.6%
OCF growth 3Y-25.39%
OCF growth 5Y-2.96%

ENHABIT INC / EHAB FAQ

What is the fundamental rating for EHAB stock?

ChartMill assigns a fundamental rating of 4 / 10 to EHAB.


What is the valuation status for EHAB stock?

ChartMill assigns a valuation rating of 6 / 10 to ENHABIT INC (EHAB). This can be considered as Fairly Valued.


Can you provide the profitability details for ENHABIT INC?

ENHABIT INC (EHAB) has a profitability rating of 4 / 10.


What is the expected EPS growth for ENHABIT INC (EHAB) stock?

The Earnings per Share (EPS) of ENHABIT INC (EHAB) is expected to grow by 165.2% in the next year.